Skip to main content
. 2022 Nov 22;7(22):e161870. doi: 10.1172/jci.insight.161870

Figure 1. Serum metabolic profiling in patients with rosacea identified by targeted metabolomics.

Figure 1

(A) The summary of detected metabolite counts in each metabolite class. (B) The relative abundance of each metabolite classes in different groups is shown in the stacked bar chart. (C) PLS-DA score plots from the healthy (n = 63) and rosacea groups (n = 57). (D) OPLS-DA score plots from the healthy (n = 63) and rosacea groups (n = 57). (E) Visualization of 43 serum differential metabolite expression values in 2 groups by heatmap. *P < 0.05, ***P < 0.001 by 2-tailed unpaired Student’s t test. HC, healthy control (blue); Rosacea, rosacea patients (red); SCFAs, short chain fatty acids.